CA2641733C - Scaffolds for organ reconstruction and augmentation - Google Patents

Scaffolds for organ reconstruction and augmentation Download PDF

Info

Publication number
CA2641733C
CA2641733C CA2641733A CA2641733A CA2641733C CA 2641733 C CA2641733 C CA 2641733C CA 2641733 A CA2641733 A CA 2641733A CA 2641733 A CA2641733 A CA 2641733A CA 2641733 C CA2641733 C CA 2641733C
Authority
CA
Canada
Prior art keywords
construct
matrix
bladder
scaffold
neo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2641733A
Other languages
English (en)
French (fr)
Other versions
CA2641733A1 (en
Inventor
Timothy A. Bertram
Andrew Bruce
Deepak Jain
Manuel Jayo
John Ludlow
Darrell Mccoy
Richard Payne
Namrata Sangha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tengion Inc
Original Assignee
Tengion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tengion Inc filed Critical Tengion Inc
Priority to CA2871840A priority Critical patent/CA2871840A1/en
Publication of CA2641733A1 publication Critical patent/CA2641733A1/en
Application granted granted Critical
Publication of CA2641733C publication Critical patent/CA2641733C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/042—Urinary bladders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3826—Muscle cells, e.g. smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/383—Nerve cells, e.g. dendritic cells, Schwann cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3882—Hollow organs, e.g. bladder, esophagus, urether, uterus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A61L27/3891—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types as distinct cell layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/047—Urethrae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/048—Ureters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1347—Smooth muscle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/25—Urinary tract cells, renal cells
    • C12N2502/253—Bladder cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
CA2641733A 2006-02-10 2007-02-12 Scaffolds for organ reconstruction and augmentation Expired - Fee Related CA2641733C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2871840A CA2871840A1 (en) 2006-02-10 2007-02-12 Scaffolds for organ reconstruction and augmentation

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77275406P 2006-02-10 2006-02-10
US60/772,754 2006-02-10
PCT/US2007/003709 WO2007095193A2 (en) 2006-02-10 2007-02-12 Scaffolds for organ reconstruction and augmentation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2871840A Division CA2871840A1 (en) 2006-02-10 2007-02-12 Scaffolds for organ reconstruction and augmentation

Publications (2)

Publication Number Publication Date
CA2641733A1 CA2641733A1 (en) 2007-08-23
CA2641733C true CA2641733C (en) 2015-03-31

Family

ID=38372067

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2641733A Expired - Fee Related CA2641733C (en) 2006-02-10 2007-02-12 Scaffolds for organ reconstruction and augmentation
CA2871840A Abandoned CA2871840A1 (en) 2006-02-10 2007-02-12 Scaffolds for organ reconstruction and augmentation

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2871840A Abandoned CA2871840A1 (en) 2006-02-10 2007-02-12 Scaffolds for organ reconstruction and augmentation

Country Status (5)

Country Link
US (3) US7918897B2 (enExample)
EP (1) EP1987134A4 (enExample)
JP (3) JP5416415B2 (enExample)
CA (2) CA2641733C (enExample)
WO (1) WO2007095193A2 (enExample)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2307567C (en) * 1997-10-31 2009-01-20 Children's Medical Center Corporation Polymer matrix/cell construct for bladder reconstruction
WO2003076476A2 (en) * 2002-01-14 2003-09-18 Ansell Healthcare Products, Inc. Magnetically detectable latex articles
US9788821B2 (en) * 2005-04-29 2017-10-17 Cook Biotech Incorporated Physically modified extracellular matrix materials and uses thereof
US7846728B2 (en) * 2006-10-13 2010-12-07 BioStruxs, LLC Tissue engineering in vivo with vascularized scaffolds
EP2082030A2 (en) * 2006-10-20 2009-07-29 Keracure, Inc. Devices with cells cultured on flexible supports
EP3192369B1 (en) * 2007-04-12 2018-12-12 The General Hospital Corporation Biomimetic vascular network
US20100070020A1 (en) 2008-06-11 2010-03-18 Nanovasc, Inc. Implantable Medical Device
US20090069904A1 (en) * 2007-09-12 2009-03-12 Applied Medical Research Biomaterial including micropores
US20090227026A1 (en) * 2008-02-14 2009-09-10 Rapoport H Scott Tissue engineering scaffolds
WO2009120966A2 (en) 2008-03-27 2009-10-01 The Cleveland Clinic Foundation Reinforced tissue graft
US20130116799A1 (en) 2008-03-27 2013-05-09 The Cleveland Clinic Foundation Reinforced tissue graft
US9682173B2 (en) * 2008-06-11 2017-06-20 The Children's Mercy Hospital Solutions for tissue engineering and methods of use
AU2009259828B2 (en) * 2008-06-20 2014-05-08 Cook Biotech Incorporated Compressible/expandable medical graft products, and methods for applying hemostasis
NZ626419A (en) * 2008-11-04 2016-02-26 Regenmedtx Llc Cell-scaffold constructs
EP2358375B1 (en) 2008-11-12 2013-07-24 Tengion, Inc. Isolated renal cells and uses thereof
EP2395941B1 (en) * 2009-02-11 2017-01-11 Nanyang Technological University Multi-layered surgical prosthesis
JP5662427B2 (ja) 2009-06-04 2015-01-28 ローテーション メディカル インコーポレイテッドＲｏｔａｔｉｏｎ Ｍｅｄｉｃａｌ，Ｉｎｃ． 目的の組織にシート状材料を固定するための装置
US8758447B2 (en) * 2009-06-30 2014-06-24 Ethicon, Inc. Device and method for repair of urological structures
US20100331963A1 (en) * 2009-06-30 2010-12-30 Jackie Donners Method of Making Suture-Less Hollow Scaffolds
US20110224800A1 (en) * 2010-03-09 2011-09-15 Ludlow John W Cell-scaffold constructs
WO2011137394A1 (en) * 2010-04-29 2011-11-03 BioStruxs, LLC Breast reconstruction device and methods
US20150030657A1 (en) * 2010-05-03 2015-01-29 Tengion, Inc. Smooth muscle cell constructs
ES2641287T3 (es) * 2010-05-06 2017-11-08 Primed Halberstadt Medizintechnik Gmbh Prótesis de vejiga urinaria para implantación subcutánea
TWI690320B (zh) 2010-05-12 2020-04-11 開曼群島商英瑞金公司 生物活性腎細胞
US9668846B2 (en) 2010-05-24 2017-06-06 Drexel University Textile-templated electrospun anisotropic scaffolds for tissue engineering and regenerative medicine
WO2011156642A1 (en) 2010-06-11 2011-12-15 Tengion, Inc. Erythropoietin-expressing adipose cell populations
KR102302069B1 (ko) 2010-11-10 2021-09-14 인리젠 장기 확대를 위한 주사가능 제제
JP5878181B2 (ja) 2011-01-06 2016-03-08 ヒューマサイト 組織工学構築物
US8597948B2 (en) * 2011-03-10 2013-12-03 First Principles, Inc. Cloned biological material medical device and method thereof
ITMI20110387A1 (it) 2011-03-11 2012-09-12 Antonio Sambusseti Emisfera per l'ampliamento vescicale in pazienti con bassa compliance
ITMI20110386A1 (it) * 2011-03-11 2012-09-12 Antonio Sambusseti Cuffia riassorbibile per l'ampliamento vescicale in pazienti con bassa compliance
ES2689265T3 (es) 2011-11-04 2018-11-12 Inregen Cribado de fármacos y ensayos de potencia
ITMI20120380A1 (it) * 2012-03-12 2013-09-13 Antonio Sambusseti Cuffia riassorbibile migliorata per l'ampliamento vescicale in pazienti con bassa compliance o per la sostituzione di una vasta porzione di vescica a seguito di bilarzia
ITMI20120381A1 (it) * 2012-03-12 2013-09-13 Antonio Sambusseti Patch riassorbibile in pga rinforzato per la sostituzione di una porzione di parete vescicale a seguito di vescitectomia parziale
WO2013148264A1 (en) * 2012-03-30 2013-10-03 University Of Rochester Controlling extracellular matrix protein microstructure with ultrasound
US20150064141A1 (en) 2012-04-05 2015-03-05 The Regents Of The University Of California Regenerative sera cells and mesenchymal stem cells
ITMI20121555A1 (it) * 2012-09-19 2014-03-20 Gianni Cancarini Endoprotesi ortotopica di vescica artificiale
US10952806B2 (en) 2012-09-25 2021-03-23 Axogen Corporation Materials and methods for protecting against neuromas
DK3782659T3 (da) * 2012-09-25 2025-12-01 Axogen Corp Materialer og fremgangsmåder til beskyttelse mod neuromer
ITMI20121743A1 (it) * 2012-10-16 2014-04-17 Gianni Cancarini Endoprotesi ortotopica di vescica artificiale
EP3901251B9 (en) 2012-10-24 2025-06-18 ProKidney Renal cell populations and uses thereof
ITMI20121809A1 (it) * 2012-10-24 2014-04-25 Antonio Sambusseti Sistema di anastomosi per un'endoprotesi vescicale
KR102349183B1 (ko) 2013-05-08 2022-01-07 인리젠 단리된 신장 세포를 포함하는 오가노이드 및 이의 용도
ITMI20130799A1 (it) * 2013-05-15 2014-11-16 Antonio Sambusseti Endoprotesi ortotopica di vescica artificiale con migliorate proprieta' antireflusso
CN103393482B (zh) * 2013-08-14 2016-04-06 北京瑞健高科生物科技有限公司 一种基于组织基质材料的乳房假体支撑装置及其制备方法
ITMI20132071A1 (it) * 2013-12-12 2015-06-13 Gianni Cancarini Endoprotesi ortotopica di vescica artificiale
ES2745563T3 (es) 2014-03-11 2020-03-02 Mri Inc Cubierta posterior híbrida y soporte de montaje para una pantalla electrónica
BR112016023550A2 (pt) * 2014-04-14 2017-08-15 sambusseti Antonio endoprótese ortotópica de bexiga artificial e kit de dita endoprótese
BR112017006558A2 (pt) * 2014-09-30 2018-04-10 sambusseti Antonio endoprótese de bexiga artificial ortotópica
US10350051B2 (en) 2014-09-30 2019-07-16 Antonio Sambusseti Orthotopic artificial bladder endoprosthesis
FR3045664A1 (fr) * 2015-12-17 2017-06-23 Oreal Membrane pour tissu reconstruit comprenant des pores de plusieurs diametres
AU2017257943B2 (en) * 2016-04-28 2020-04-30 National University Corporation Nagoya Institute Of Technology Method for manufacturing bone-regeneration material comprising biodegradable fibers by using electrospinning method
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
US9750591B1 (en) 2016-07-29 2017-09-05 Sam Sultan Systems and methods for assisting patients in emptying their bladder efficiently
IL305539B2 (en) * 2017-04-25 2025-03-01 Axogen Corp Materials and methods for protecting against neuromas
WO2018237170A1 (en) 2017-06-21 2018-12-27 Bertram Timothy A BIOACTIVE IMMUNO-PRIVILEGE RENAL CELLS FOR THE TREATMENT OF RENAL DISEASE
WO2019070960A1 (en) * 2017-10-04 2019-04-11 Sampaio Luiz C ARTIFICIAL BLOOD BARRIER
AU2019299519B2 (en) * 2018-07-02 2025-03-06 Incept Llc Methods and devices for in situ formed nerve cap
US12447179B2 (en) 2018-08-31 2025-10-21 Prokidney Compositions comprising cell-delivered vesicles and uses thereof
IL312320A (en) * 2018-10-03 2024-06-01 Estab Labs S A Scaffolding for implantable medical devices and methods of use thereof
JP7341047B2 (ja) * 2019-12-25 2023-09-08 株式会社荏原製作所 アンチモン吸着材並びにアンチモン含有液の処理装置及び処理方法
CN113384379B (zh) * 2021-06-17 2022-12-02 深圳华越再生医学生物科技有限公司 一种用以包裹移植脏器的装置

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2255877B1 (enExample) 1973-12-28 1976-10-08 Rhone Poulenc Ind
US5514378A (en) 1993-02-01 1996-05-07 Massachusetts Institute Of Technology Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
DE4324085A1 (de) 1993-07-17 1995-01-19 Basf Ag Verfahren zur Zersetzung organischer Halogenverbindungen in staubhaltigen Abgasen
US5654273A (en) 1994-09-22 1997-08-05 Children's Medical Center Corporation Synducin mediated modulation of tissue repair
US5586438A (en) 1995-03-27 1996-12-24 Organ, Inc. Portable device for preserving organs by static storage or perfusion
JPH11508151A (ja) * 1995-04-07 1999-07-21 パーデュー・リサーチ・ファウンデーション 膀胱再建方法及び膀胱再建用組織グラフト
US5755791A (en) 1996-04-05 1998-05-26 Purdue Research Foundation Perforated submucosal tissue graft constructs
FR2759575B1 (fr) * 1997-02-14 1999-04-30 Assist Publ Hopitaux De Paris Implant artificiel destine au remplacement de l'appareil excreteur urinaire chez l'etre humain
EP2075015B1 (en) * 1997-07-03 2015-03-11 Massachusetts Institute of Technology Tissue-engineered constructs
WO1999010663A1 (de) 1997-08-26 1999-03-04 Luk Getriebe-Systeme Gmbh Hydrodynamischer drehmomentwandler
CA2307567C (en) 1997-10-31 2009-01-20 Children's Medical Center Corporation Polymer matrix/cell construct for bladder reconstruction
AU1588099A (en) 1997-11-17 1999-06-07 Beth Israel Deaconess Medical Center Hybrid tissues for tissue engineering
DE19912472B4 (de) 1999-03-18 2011-03-17 Wassermann, Helmut, Prof. Künstliches Harnableitungssystem
WO2000056246A1 (de) 1999-03-18 2000-09-28 Helmut Wassermann Künstliches harnableitungssystem
US7131996B2 (en) 1999-03-18 2006-11-07 Helmut Wasserman Artificial urinary diversion device
US6432712B1 (en) 1999-11-22 2002-08-13 Bioscience Consultants, Llc Transplantable recellularized and reendothelialized vascular tissue graft
US6428802B1 (en) 1999-12-29 2002-08-06 Children's Medical Center Corp. Preparing artificial organs by forming polylayers of different cell populations on a substrate
EP1448247B1 (en) * 2001-11-16 2011-02-16 Children's Medical Center Corporation Creation of tissue engineered female reproductive organs
US20040029266A1 (en) 2002-08-09 2004-02-12 Emilio Barbera-Guillem Cell and tissue culture device
JPWO2005089823A1 (ja) * 2004-03-19 2008-01-31 独立行政法人科学技術振興機構 再生管腔臓器着生剤、着生可能型再生管腔臓器、着生可能型再生管腔臓器の製造方法、及び管腔臓器の再生着生方法

Also Published As

Publication number Publication date
JP5416415B2 (ja) 2014-02-12
WO2007095193A2 (en) 2007-08-23
CA2871840A1 (en) 2007-08-23
US20140107804A1 (en) 2014-04-17
JP2009525832A (ja) 2009-07-16
US8696760B2 (en) 2014-04-15
EP1987134A4 (en) 2012-08-01
JP2012139598A (ja) 2012-07-26
US7918897B2 (en) 2011-04-05
CA2641733A1 (en) 2007-08-23
JP2014195737A (ja) 2014-10-16
WO2007095193A3 (en) 2008-11-20
US20070276507A1 (en) 2007-11-29
US20110257726A1 (en) 2011-10-20
EP1987134A2 (en) 2008-11-05

Similar Documents

Publication Publication Date Title
US7918897B2 (en) Scaffolds for organ reconstruction and augmentation
US20070275363A1 (en) Bioreactor for organ reconstruction and augmentation
US8128707B2 (en) Bladder reconstruction
AU778222B2 (en) Methods and compositions for reconstruction of multilayered tissue structures
AU2011248232B2 (en) Smooth muscle cell constructs
KR20130005285A (ko) 세포 골격 구조물
HK1232810A1 (en) Smooth muscle cell constructs
HK1182652B (en) Smooth muscle cell constructs

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20210831

MKLA Lapsed

Effective date: 20200212